Table 5 Clinical outcomes in patient populations in ACS and non-ACS patients
Variable | All patients | Non ACS | ACS | p value |
|---|---|---|---|---|
Number of patients | 447 | 334 | 113 | – |
Patients with clinical follow-up | 384 (85.9 %) | 301 (90.3 %) | 83 (73.5 %) | 0.021 |
Follow-up time (months) | 9.4 ± 1.7 | 9.5 ± 1.7 | 9.4 ± 1.6 | 0.875 |
30-day MACE | 1 (0.3 %) | 1 (0.3 %) | 0 (0.0 %) | 0.599 |
30-day TLR | 1 (0.3 %) | 1 (0.3 %) | 0 (0.0 %) | 0.599 |
30-day MI | 1 (0.3 %) | 1 (0.3 %) | 0 (0.0 %) | 0.599 |
30-day cardiac death | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | – |
9-month MACE | 18 (4.7 %) | 15 (5.0 %) | 3 (3.6 %) | 0.601 |
9-month TLR | 14 (3.6 %) | 13 (4.3 %) | 1 (1.2 %) | 0.180 |
9-month MI | 7 (1.8 %) | 4 (1.3 %) | 3 (3.6 %) | 0.168 |
9-month cardiac death | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | – |
9-month vessel thrombosis | 3 (0.8 %) | 3 (1.1 %) | 0 (0.0 %) | 0.356 |
Target lesion | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | – |
Target vessel | 2 (0.5 %) | 2 (0.7 %) | 0 (0.0 %) | 0.457 |
Non-target vessel | 1 (0.3 %) | 1 (0.3 %) | 0 (0.0 %) | 0.599 |